TP53 and cancer: This is in contrast to mutation in RPs (without concurrent TP53 mutation) that are primarily associated with ribosomopathies.25 Here, we review the current knowledge and new perspectives with respect to diseases linked to mutations or deletions in RP genes and the molecular mechanisms driving cancer susceptibility.